🎉 M&A multiples are live!
Check it out!

Aelis Farma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Aelis Farma and similar public comparables like Galapagos, Benevolent AI, and Vivoryon Therapeutics.

Aelis Farma Overview

About Aelis Farma

Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.


Founded

2013

HQ

France
Employees

23

Website

aelisfarma.com

Financials

LTM Revenue $5.3M

LTM EBITDA n/a

EV

$10.2M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Aelis Farma Financials

Aelis Farma has a last 12-month revenue of $5.3M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Aelis Farma achieved revenue of $9.7M and an EBITDA of -$4.9M.

Aelis Farma expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Aelis Farma valuation multiples based on analyst estimates

Aelis Farma P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $4.1M $9.7M XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$15.2M -$4.9M XXX XXX XXX
EBITDA Margin -370% -51% XXX XXX XXX
Net Profit $0.6M -$15.3M XXX XXX XXX
Net Margin 15% -158% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Aelis Farma Stock Performance

As of April 15, 2025, Aelis Farma's stock price is EUR 1 (or $1).

Aelis Farma has current market cap of EUR 17.0M (or $18.3M), and EV of EUR 9.5M (or $10.2M).

See Aelis Farma trading valuation data

Aelis Farma Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$10.2M $18.3M XXX XXX XXX XXX $-0.28

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Aelis Farma Valuation Multiples

As of April 15, 2025, Aelis Farma has market cap of $18.3M and EV of $10.2M.

Aelis Farma's trades at 1.9x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Aelis Farma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Aelis Farma and 10K+ public comps

Aelis Farma Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $10.2M XXX XXX XXX
EV/Revenue 1.1x XXX XXX XXX
EV/EBITDA -2.1x XXX XXX XXX
P/E -3.4x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -0.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Aelis Farma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Aelis Farma Valuation Multiples

Aelis Farma's NTM/LTM revenue growth is 20%

Aelis Farma's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.7M for the same period.

Over next 12 months, Aelis Farma's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Aelis Farma's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Aelis Farma and other 10K+ public comps

Aelis Farma Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 138% XXX XXX XXX XXX
EBITDA Margin -51% XXX XXX XXX XXX
EBITDA Growth -68% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -30% XXX XXX XXX XXX
Revenue per Employee $0.4M XXX XXX XXX XXX
Opex per Employee $0.7M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 12% XXX XXX XXX XXX
R&D Expenses to Revenue 179% XXX XXX XXX XXX
Opex to Revenue 171% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Aelis Farma Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Aelis Farma M&A and Investment Activity

Aelis Farma acquired  XXX companies to date.

Last acquisition by Aelis Farma was  XXXXXXXX, XXXXX XXXXX XXXXXX . Aelis Farma acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Aelis Farma

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Aelis Farma

When was Aelis Farma founded? Aelis Farma was founded in 2013.
Where is Aelis Farma headquartered? Aelis Farma is headquartered in France.
How many employees does Aelis Farma have? As of today, Aelis Farma has 23 employees.
Who is the CEO of Aelis Farma? Aelis Farma's CEO is Mr. Pier Vincenzo Piazza.
Is Aelis Farma publicy listed? Yes, Aelis Farma is a public company listed on PAR.
What is the stock symbol of Aelis Farma? Aelis Farma trades under AELIS ticker.
When did Aelis Farma go public? Aelis Farma went public in 2022.
Who are competitors of Aelis Farma? Similar companies to Aelis Farma include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Aelis Farma? Aelis Farma's current market cap is $18.3M
What is the current revenue of Aelis Farma? Aelis Farma's last 12-month revenue is $5.3M.
What is the current EV/Revenue multiple of Aelis Farma? Current revenue multiple of Aelis Farma is 1.9x.
What is the current revenue growth of Aelis Farma? Aelis Farma revenue growth between 2023 and 2024 was 138%.
Is Aelis Farma profitable? Yes, Aelis Farma is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.